Sean F. Scanlan
Chief Innovation Officer · TREACE MEDICAL CONCEPTS, INC.
Individual
- 2025
- Aug 12, 2026
- 7
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Sean F. Scanlan files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- John T. Treace - $1.45M in TMCI purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Sean F. Scanlan?
Sean F. Scanlan is a corporate insider, tracked as Chief Innovation Officer of TREACE MEDICAL CONCEPTS, INC. (TMCI). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Sean F. Scanlan submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
